Literature DB >> 131515

Generalized exfoliative dermatitis from ethylenediamine.

J W Petrozzi, R N Shore.   

Abstract

A patient with a history of allergic reaction to an antibiotic cream (Mycolog [mixture of nystatin, neomycin sulfate, gramicidin, and triamcinolone acetonide]) was treated with aminophylline. A generalized exfoliative dermatitis resulted. The reaction was attributable to ethylenediamine hydrochloride, which is a component of both agents. Recognition of the potential for systemic medications to induce similar reactions in patients who are allergic to related topical preparations is important when prescribing systemic agents.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 131515

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  7 in total

1.  Aminophylline-induced exfoliative dermatitis: cause and implications.

Authors:  D W Nierenberg; F S Glazener
Journal:  West J Med       Date:  1982-10

2.  Contact dermatitis attributed to ethylenediamine.

Authors:  M I White; W S Douglas; R A Main
Journal:  Br Med J       Date:  1978-02-18

Review 3.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

4.  Generalised allergic reactions to aminophylline.

Authors:  P J Thompson; W R Gibb; P Cole; K M Citron
Journal:  Thorax       Date:  1984-08       Impact factor: 9.139

Review 5.  Ethylenediamine, profile of a sensitizing excipient.

Authors:  J Zuidema
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

6.  Comparative pharmacokinetics of theophylline and aminophylline in man.

Authors:  A Aslaksen; O M Bakke; T Vigander
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

7.  Allergy to the ethylenediamine component of aminophylline.

Authors:  M Toal; A Kinney; R Fulton
Journal:  Ulster Med J       Date:  1992-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.